Back to search

Netherlands· NL-2ba7bac656aa

Omegaven-Fresenius, emulsie voor infusie

A fettemulsionen product containing docosahexaeenzuur + ei fosfatiden, gezuiverd + eicosapentaeenzuur + glycerol (e 422), registered in Netherlands by Fresenius Kabi Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOmegaven-Fresenius, emulsie voor infu…ATCB05BA02REGISTER NO.NL-2ba7bac656aaPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fettemulsionen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Fettemulsionen · ATC B05BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DOCOSAHEXAEENZUUR + EI FOSFATIDEN, GEZUIVERD + EICOSAPENTAEENZUUR + GLYCEROL (E 422)
Manufacturer
Fresenius Kabi Nederland B.V.
Country
Netherlands (NL)
ATC code
B05BA02
ATC class
Fettemulsionen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    23043

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c690aea-9821-4e24-ab24-e29d16f1d83e
GET /v1/drugs/5c690aea-9821-4e24-ab24-e29d16f1d83e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Emulsie voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h23043_smpc.pdf",
  "strength": null,
  "atc_label": "Fat Emulsions",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg23043",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMOLEAAT (E 470A)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DOCOSAHEXAEENZUUR",
    "EI FOSFATIDEN, GEZUIVERD",
    "EICOSAPENTAEENZUUR",
    "GLYCEROL (E 422)",
    "TOCOFEROL, DL-ALFA (E 307)",
    "VISOLIE, HOOG GERAFFINEERD"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h23043.pdf",
  "authorised_at": "1999/04/20",
  "procedure_number": "DE/H/0139/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "23043",
  "additional_monitoring": "N"
}

See everything about fettemulsionen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.